The Effects of a Positive Expiratory Pressure (PEP) on Dyspnea and Dynamic Hyperinflation During Exercise in Chronic Obstructive Pulmonary Disease (COPD) Patients

November 13, 2008 updated by: Khon Kaen University

The Effects of a Positive Expiratory Pressure (PEP) on Dyspnea and Dynamic Hyperinflation During Exercise in COPD Patients

From the relationship between pathophysiology of chronic obstructive pulmonary disease (COPD), dyspnea, and dynamic hyperinflation during ventilatory increasing, the investigators hypothesize that

  1. Positive expiratory pressure (PEP) breathing will reduce dyspnea more than normal breathing during exercise in mild to moderate COPD patients.
  2. PEP breathing will improve dynamic hyperinflation during exercise more than normal breathing in mild to moderate COPD patients.
  3. PEP breathing will improve cardiorespiratory function during exercise than normal breathing in mild to moderate COPD patients.

Study Overview

Detailed Description

Expiratory airflow limitation is the pathophysiological hallmark of chronic obstructive pulmonary disease (COPD) that leads to air trapping and increases in dynamic hyperinflation (DH) and consequently causes dyspnea during exercise. Although pursed lips breathing is a simple technique that provides a positive back pressure may retard the airway collapsed, but previous studies showed an unsuccessful reduction of DH which might cause by insufficient back pressure. And thereby a conical positive expiratory pressure (C-PEP) has been developed in our laboratory to generate back pressure higher than pursed lips breathing. Moreover, an effect of PEP on DH has not carried out in patient with COPD. Therefore, the objective of the present study was to examine effects of a C-PEP on DH and respiratory response during exercise in patient with COPD.

Study Type

Interventional

Enrollment (Anticipated)

11

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Khon Kaen, Thailand, 40002
        • Recruiting
        • Pulmonary research room of physical therapy department, Faculty of associated medical sciences, Khon Kaen University
        • Contact:
        • Principal Investigator:
          • Tadsawiya Padkao, Bachelor

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 70 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients with stable mild-to-moderate COPD (Both stages: FEV1/FVC < 70%. Mild stage: FEV1 ≥ 80% predicted; Moderate stage: 50% ≤ FEV1 < 80% predicted according to Global Initiative Obstructive Lung Disease (GOLD) guideline).
  • Free of exacerbations for more than 4 weeks (as defined by a change to pharmacological therapy, admission to hospital or ER or unscheduled clinic visit).
  • Good communication

Exclusion Criteria:

  • Older than 70 years old
  • Musculoskeletal problems that limit mobility
  • Cardiovascular disease
  • Neurological or psychiatric illness
  • Patient on long term oxygen or domiciliary noninvasive positive pressure ventilation
  • Any other comorbidities which would affect ability to undertake exercise test

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: I
Patients breath while a conical positive expiratory pressure device during exercises

Conical positive expiratory pressure device (C-PEP) in this study was designed on the principle of expiratory flow retardation. The principle occurs when exhaling through a small tube diameter, i.e. a small straw, pursed lip breathing, or positive expiratory pressure. Expiratory retardation, results from a decrease in tube diameter, creates flow resistance during exhalation. With flow resistance, the greater the flow the greater the back pressure, and the less the flow the lower the pressure. Expiratory retardation was applied in an attempt to facilitate exhalation and to relieve the air trapping.

The optimal design was found to be: cone shape, proximal diameter is 2.0 cm, distal diameter is 0.6 cm, and length is 2.5 cm.

Subjects will rest for 10-15 minutes until HR, BP are stabilized. They will undertake 15 min of alternating quadriceps exercise (30% 1 RM) either breathing with the C-PEP device.

Active Comparator: C
Patients (normal) breath during exercise
Subjects will rest for 10-15 minutes until HR, BP are stabilized. They will undertake 15 min of alternating quadriceps exercise (30% 1 RM) either breathing normally.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Inspiratory Capacity
Time Frame: at 0th, 5th, ~20th minutes of exercises
at 0th, 5th, ~20th minutes of exercises
Borg scale
Time Frame: at 0th and 20th minutes of exercises
at 0th and 20th minutes of exercises

Secondary Outcome Measures

Outcome Measure
Time Frame
Heart Rate
Time Frame: every minutes of exercise and recovery periods
every minutes of exercise and recovery periods
Exercise time
Time Frame: at the times when participants stop exercises
at the times when participants stop exercises
Recovery time
Time Frame: the periods between end of symptomatic limited constance workload exercises to full recovery heart rate
the periods between end of symptomatic limited constance workload exercises to full recovery heart rate
Respiratory rate
Time Frame: every minutes of exercise and recovery periods
every minutes of exercise and recovery periods
Inspiratory time
Time Frame: every minutes of exercise and recovery periods
every minutes of exercise and recovery periods
Expiratory time
Time Frame: every minutes of exercise and recovery periods
every minutes of exercise and recovery periods
Sp02
Time Frame: every minutes of exercise and recovery periods
every minutes of exercise and recovery periods
PetCO2
Time Frame: every minutes of exercise and recovery periods
every minutes of exercise and recovery periods
Mouth pressure
Time Frame: every minutes of exercise periods
every minutes of exercise periods
Flow rate
Time Frame: every minutes of exercise periods
every minutes of exercise periods

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Watchara Boonsawat, Philosophy, Department of Medicine, Faculty of Medicine, Khon Kaen University
  • Study Chair: Tadsawiya Padkao, Bachelor, Physical Therapy department, Faculty of Associated Medical Sciences, Khon Kaen university
  • Study Director: Chulee CU Jones, Philosophy, Phusical Therapy Department, Faculty of Associated Medical Sciences, Khon Kaen university, Thailand

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2008

Primary Completion (Anticipated)

February 1, 2009

Study Completion (Anticipated)

February 1, 2009

Study Registration Dates

First Submitted

August 22, 2008

First Submitted That Met QC Criteria

August 22, 2008

First Posted (Estimate)

August 26, 2008

Study Record Updates

Last Update Posted (Estimate)

November 14, 2008

Last Update Submitted That Met QC Criteria

November 13, 2008

Last Verified

November 1, 2008

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Obstructive Pulmonary Disease

Clinical Trials on Conical Positive Expiratory Pressure Device (C-PEP)

3
Subscribe